title: Evaluation of arterial stiffness for predicting future cardiovascular events in patients with ST segment elevation and non-ST segment elevation myocardial infarction.
abstract: BACKGROUND
  Arterial stiffness parameters in patients who experienced MACE after acute MI have not been studied sufficiently. We investigated arterial stiffness parameters in patients with ST segment elevation (STEMI) and non-ST segment elevation myocardial infarction (NSTEMI).
  
  
  METHODS
  Ninety-four patients with acute MI (45 STEMI and 49 NSTEMI) were included in the study. Arterial stiffness was assessed noninvasively by using TensioMed Arteriograph.
  
  
  RESULTS
  Arterial stiffness parameters were found to be higher in NSTEMI group but did not achieve statistical significance apart from pulse pressure (P = 0.007). There was no significant difference at MACE rates between two groups. Pulse pressure and heart rate were also significantly higher in MACE observed group. Aortic pulse wave velocity (PWV), aortic augmentation index (AI), systolic area index (SAI), heart rate, and pulse pressure were higher; ejection fraction, the return time (RT), diastolic reflex area (DRA), and diastolic area index (DAI) were significantly lower in patients with major cardiovascular events. However, PWV, heart rate, and ejection fraction were independent indicators at development of MACE.
  
  
  CONCLUSIONS
  Parameters of arterial stiffness and MACE rates were similar in patients with STEMI and NSTEMI in one year followup. The independent prognostic indicator aortic PWV may be an easy and reliable method for determining the risk of future events in patients hospitalized with acute MI.
authors.affiliation: Sanliurfa Siverek State Hospital, 63600 Sanliurfa, Turkey.
authors.forename: Oguz
authors.initials: O
authors.lastname: Akkus
authors.forename: Durmus Yildiray
authors.initials: DY
authors.lastname: Sahin
authors.forename: Abdi
authors.initials: A
authors.lastname: Bozkurt
authors.forename: Kamil
authors.initials: K
authors.lastname: Nas
authors.forename: Kazım Serhan
authors.initials: KS
authors.lastname: Ozcan
authors.forename: Miklós
authors.initials: M
authors.lastname: Illyés
authors.forename: Ferenc
authors.initials: F
authors.lastname: Molnár
authors.forename: Serafettin
authors.initials: S
authors.lastname: Demir
authors.forename: Mücahit
authors.initials: M
authors.lastname: Tüfenk
authors.forename: Esmeray
authors.initials: E
authors.lastname: Acarturk
mesh_terms: D000368:Aged; D015415:Biomarkers; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000503:physiopathology*; D011379:Prognosis; D012372:ROC Curve; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013318:Stroke Volume; D059289:Vascular Stiffness
chemical_list: D015415:Biomarkers